On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

The DXd ADC portfolio currently consists of ENHERTU, a HER2 directed ADC, and DATROWAY, a TROP2 directed ADC, which are being jointly developed and commercialized globally with AstraZeneca.

Daiichi Sankyo Company, Limited leads in ADC tech with Enhertu, strong partnerships, revenue growth, and global market leadership. Click to know more on why DSNKY is a Buy.

Tanzi would be the third Death Row inmate to be executed in Florida this year. A 48-year-old man is to be executed by lethal injection in the southern US state of Florida on Tuesday for the April ...

The lone unrated drug was trastuzumab deruxtecan (Enhertu). Thirty-nine of the rated drugs (80%) were classed as having a high added benefit, and 9 (18%) were classified as having a low added benefit.

US biotech Cartesian Therapeutics (Nasdaq: RNAC) has reported that patients with generalized myasthenia gravis (gMG) continued to experience lasting symptom relief 12 months after treatment with its ...

A 48-year-old death row inmate in Florida is set to face the lethal injection after carrying out crimes that prompted one detective to describe him as a 'fledgling serial killer'. Michael Tanzi was ...

ENHERTU® Plus Pertuzumab Demonstrated Highly Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival Versus THP as First-Line Therapy for Patients with HER2 ...

Michael Tanzi was pronounced dead at 6:12 p.m. following a three-drug injection at Florida State Prison for the April 2000 strangling of Janet Acosta. Michael Tanzi, 48, was convicted for the 2000 ...

The risk of disease progression or death was reduced by 79% with nivolumab/ipilimumab compared with chemotherapy. The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in ...